Carlisle Companies News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.09.17	Design and Construction Amnesia: Liberty Building Forensics Group Says, "We Have Lost our Minds and it is Causing Catastrophic Mold and Moisture Building Failures." (PR Newswire)
08.09.17	Initiating Research Reports on Rubber & Plastics Equities -- Goodyear Tire & Rubber, Carlisle, Cooper Tire & Rubber, and Trinseo (PR Newswire)
01.09.17	SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly Files Early Warning Report (PR Newswire)
28.08.17	CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform (PR Newswire)
22.08.17	Clutch Announces Top Agencies and Developers in Philadelphia and Atlanta (PR Newswire)
25.07.17	Carlisle Companies Inc. Profit Drops 11% In Q2 (RTTNews)
25.07.17	HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) Now Available in the United States for Patients with Hereditary Angioedema (PR Newswire)
21.07.17	CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]) (PR Newswire)
19.07.17	FDA Accepts CSL Behring's Supplemental Biologics License Application for Hizentra® Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Indication (PR Newswire)
12.07.17	New Data Demonstrate Prophylactic Treatment with IDELVION® Reduces Bleed Frequency and Has Potential to Positively Impact Patients with Haemophilia B (PR Newswire)
11.07.17	CSL Behring Awards Researchers to Advance Immunoglobulin Therapy in Treating Neurological Disorders (PR Newswire)
10.07.17	New Findings Show AFSTYLA® Provides Long-lasting Efficacy without Increased Product Consumption for Prophylactic and On-Demand Treatment of Haemophilia A (PR Newswire)
06.07.17	New Data for Two Leading Haemophilia Medicines -- AFSTYLA® and IDELVION® -- to be Presented at the International Society on Thrombosis and Haemostasis Congress 2017 (PR Newswire)
30.06.17	How These Rubber and Plastics Stocks are Performing? -- Goodyear Tire & Rubber, Carlisle, Cooper Tire & Rubber, and Trinseo (PR Newswire)
23.06.17	FDA Approves HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]), First and Only Subcutaneous Preventive Treatment for Hereditary Angioedema (PR Newswire)
13.06.17	CSL to acquire majority stake in Chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologicals Products (PR Newswire)
19.05.17	New Innovation in the Fight Against Hemophilia Earns CSL Behring the NORD 2017 Industry Innovation Award (PR Newswire)
28.04.17	Carlisle Companies Inc. Q1 Income Declines 10% (RTTNews)
25.04.17	Wirecard North America and CSL Plasma Launch First Cash-Back Donor Prepaid Card (PR Newswire)
25.04.17	Wirecard North America and CSL Plasma Launch First Cash-Back Donor Prepaid Card (PR Newswire)
19.04.17	Therapeutic Goods Administration Approves AFSTYLA® - CSL Behring's Novel Recombinant Haemophilia A Treatment (PR Newswire)
10.04.17	Improving Access to Lifesaving Treatments for Bleeding Disorders in the Developing World (PR Newswire)
07.04.17	Technical Reports on Consumer Goods Equities -- Travelport, Liberty TripAdvisor, Brunswick, and Carlisle (PR Newswire)
31.03.17	Jeffrey Modell Foundation to Open the First North African Network for Primary Immunodeficiencies (PR Newswire)
29.03.17	CSL Behring Awards Grant To Patient Groups To Develop Innovative Ways To Advocate For Patients (PR Newswire)
29.03.17	/DISREGARD RELEASE: CSL Behring/ (PR Newswire)
22.03.17	New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring's Subcutaneous C1-Esterase Inhibitor in HAE Patients (PR Newswire)
01.03.17	Largest Ever CIDP Clinical Study Completed (PR Newswire)
15.02.17	Carlisle Companies Names Robert Roche VP And CFO (RTTNews)
14.02.17	FDA Accepts CSL Behring's Biologics License Application Supplement for Using Privigen® to Treat Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a Rare Neurological Condition (PR Newswire)
09.02.17	Carlisle Companies Inc. Q4 Income Rises 6% (RTTNews)
02.12.16	The Lancet Respiratory Medicine Publishes RAPID Extension Study Data on Effect of Zemaira® [Alpha1-Proteinase Inhibitor (Human)] in Patients with Alpha-1 Antitrypsin Deficiency (AATD) (PR Newswire)
25.10.16	Carlisle Companies Inc. Bottom Line Rises 9% In Q3 (RTTNews)
29.08.16	Seqirus Gets FDA Approval For AFLURIA QUADRIVALENT (RTTNews)
26.07.16	Carlisle Companies Inc. Q2 Income Climbs 21% (RTTNews)
27.04.16	Carlisle Companies Inc. Reveals 74% Rise In Q1 Earnings (RTTNews)
04.02.16	Carlisle Companies Q4 Results Climb, Top View; Sees Sales Growth In FY16 (RTTNews)
04.02.16	Carlisle Companies Inc. Profit Rises 54% In Q4 (RTTNews)
11.12.15	Carlisle Names Christian Koch To Succeed David Roberts As CEO (RTTNews)
21.10.15	Carlisle Companies Inc. Bottom Line Rises 19% In Q3 (RTTNews)
05.08.15	Carlisle Companies Boosts Dividend 20% (RTTNews)
23.07.15	Carlisle Q2 Profit, Revenue Climb - Quick Facts (RTTNews)
23.07.15	EARNINGS SUMMARY: Details of Carlisle Companies Inc. Q2 Earnings Report (RTTNews)
24.06.15	CSL Behring Announces Pivotal Data Of Novel RVIII-SingleChain Therapy (RTTNews)
25.03.15	FTC Okays Carlisle's Purchase Of Liquid Finishing Business Assets From Graco (RTTNews)
19.01.15	Carlisle Says Weakness In CCM, CBF Segments To Hurt Q4 Results (RTTNews)
21.10.14	Carlisle Q3 Profit Rises - Quick Facts (RTTNews)
08.10.14	Graco To Sell Liquid Finishing Business Assets To Carlisle For $590 Mln Cash (RTTNews)
08.10.14	Graco To Sell Liquid Finishing Business Assets To Carlisle For $590 Mln (RTTNews)
08.10.14	Carlisle To Buy Liquid Finishing Business Assets From Graco - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Carlisle Companies Inc.

Aktien Top/Flop

Meistgelesene Nachrichten